Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study

Identifieur interne : 003513 ( Main/Exploration ); précédent : 003512; suivant : 003514

Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study

Auteurs : Alex L. C. Tam [Canada] ; Neeru Gupta [Canada] ; Zhexue Zhang [Canada] ; Yeni H. Yücel [Canada]

Source :

RBID : PMC:3763898

Abstract

Purpose

Ocular lymphatics have been recently shown to contribute to aqueous humor outflow. It is not yet known whether lymphatic outflow can be stimulated by pharmacological agents. Here we determine whether latanoprost, a prostaglandin F2 alpha analog commonly used to lower IOP to treat glaucoma, increases lymphatic drainage from the eye.

Methods

Lymphatic drainage in mice was assessed in vivo, in 11 latanoprost-treated and 11 control animals using hyperspectral imaging at multiple times following quantum dot (QD) injection into the eye. QD signal intensity was also measured in tissue sections using hyperspectral imaging.

Results

In the latanoprost-treated group, lymphatic drainage rate into the submandibular lymph node was increased compared with controls (1.23 ± 1.06 hours−1 vs. 0.30 ± 0.17 hours−1, mean ± SD, P < 0.02). Total QD signal intensity in the submandibular lymph node was greater in the latanoprost-treated group compared with controls (10.55 ± 1.12 vs. 9.48 ± 1.24, log scale, P < 0.05).

Conclusions

This is the first evidence that latanoprost increases lymphatic drainage from the eye. The pharmacological manipulation of this newly identified lymphatic outflow pathway may be relevant to treatments aimed at lowering intraocular pressure in glaucoma.

Translational Relevance

This is the first evidence that a prostaglandin drug widely prescribed for glaucoma, enhances lymphatic drainage from the eye. The pharmacological stimulation of this newly identified outflow pathway may be highly relevant to treatments aimed at lowering IOP to prevent blindness from glaucoma.


Url:
DOI: 10.1167/tvst.2.5.3
PubMed: 24049723
PubMed Central: 3763898


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study</title>
<author>
<name sortKey="Tam, Alex L C" sort="Tam, Alex L C" uniqKey="Tam A" first="Alex L. C." last="Tam">Alex L. C. Tam</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gupta, Neeru" sort="Gupta, Neeru" uniqKey="Gupta N" first="Neeru" last="Gupta">Neeru Gupta</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff4">Glaucoma and Nerve Protection Unit, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Glaucoma and Nerve Protection Unit, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Zhexue" sort="Zhang, Zhexue" uniqKey="Zhang Z" first="Zhexue" last="Zhang">Zhexue Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yucel, Yeni H" sort="Yucel, Yeni H" uniqKey="Yucel Y" first="Yeni H." last="Yücel">Yeni H. Yücel</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:aff id="aff5">Ophthalmic Pathology Laboratory, University of Toronto, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Ophthalmic Pathology Laboratory, University of Toronto, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24049723</idno>
<idno type="pmc">3763898</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763898</idno>
<idno type="RBID">PMC:3763898</idno>
<idno type="doi">10.1167/tvst.2.5.3</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">003214</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003214</idno>
<idno type="wicri:Area/Pmc/Curation">003213</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003213</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002233</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002233</idno>
<idno type="wicri:Area/Ncbi/Merge">005D60</idno>
<idno type="wicri:Area/Ncbi/Curation">005D60</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">005D60</idno>
<idno type="wicri:Area/Main/Merge">003519</idno>
<idno type="wicri:Area/Main/Curation">003513</idno>
<idno type="wicri:Area/Main/Exploration">003513</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study</title>
<author>
<name sortKey="Tam, Alex L C" sort="Tam, Alex L C" uniqKey="Tam A" first="Alex L. C." last="Tam">Alex L. C. Tam</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gupta, Neeru" sort="Gupta, Neeru" uniqKey="Gupta N" first="Neeru" last="Gupta">Neeru Gupta</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff4">Glaucoma and Nerve Protection Unit, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Glaucoma and Nerve Protection Unit, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Zhexue" sort="Zhang, Zhexue" uniqKey="Zhang Z" first="Zhexue" last="Zhang">Zhexue Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Yucel, Yeni H" sort="Yucel, Yeni H" uniqKey="Yucel Y" first="Yeni H." last="Yücel">Yeni H. Yücel</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Keenan Research Centre at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:aff id="aff5">Ophthalmic Pathology Laboratory, University of Toronto, St. Michael's Hospital, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Ophthalmic Pathology Laboratory, University of Toronto, St. Michael's Hospital, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Translational Vision Science & Technology</title>
<idno type="eISSN">2164-2591</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="st1">
<title>Purpose</title>
<p>Ocular lymphatics have been recently shown to contribute to aqueous humor outflow. It is not yet known whether lymphatic outflow can be stimulated by pharmacological agents. Here we determine whether latanoprost, a prostaglandin F2 alpha analog commonly used to lower IOP to treat glaucoma, increases lymphatic drainage from the eye.</p>
</sec>
<sec id="st2">
<title>Methods</title>
<p>Lymphatic drainage in mice was assessed in vivo, in 11 latanoprost-treated and 11 control animals using hyperspectral imaging at multiple times following quantum dot (QD) injection into the eye. QD signal intensity was also measured in tissue sections using hyperspectral imaging.</p>
</sec>
<sec id="st3">
<title>Results</title>
<p>In the latanoprost-treated group, lymphatic drainage rate into the submandibular lymph node was increased compared with controls (1.23 ± 1.06 hours
<sup>−1</sup>
vs. 0.30 ± 0.17 hours
<sup>−1</sup>
, mean ± SD,
<italic>P</italic>
< 0.02). Total QD signal intensity in the submandibular lymph node was greater in the latanoprost-treated group compared with controls (10.55 ± 1.12 vs. 9.48 ± 1.24, log scale,
<italic>P</italic>
< 0.05).</p>
</sec>
<sec id="st4">
<title>Conclusions</title>
<p>This is the first evidence that latanoprost increases lymphatic drainage from the eye. The pharmacological manipulation of this newly identified lymphatic outflow pathway may be relevant to treatments aimed at lowering intraocular pressure in glaucoma.</p>
</sec>
<sec id="st5">
<title>Translational Relevance</title>
<p>This is the first evidence that a prostaglandin drug widely prescribed for glaucoma, enhances lymphatic drainage from the eye. The pharmacological stimulation of this newly identified outflow pathway may be highly relevant to treatments aimed at lowering IOP to prevent blindness from glaucoma.</p>
</sec>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Tam, Alex L C" sort="Tam, Alex L C" uniqKey="Tam A" first="Alex L. C." last="Tam">Alex L. C. Tam</name>
</noRegion>
<name sortKey="Gupta, Neeru" sort="Gupta, Neeru" uniqKey="Gupta N" first="Neeru" last="Gupta">Neeru Gupta</name>
<name sortKey="Yucel, Yeni H" sort="Yucel, Yeni H" uniqKey="Yucel Y" first="Yeni H." last="Yücel">Yeni H. Yücel</name>
<name sortKey="Yucel, Yeni H" sort="Yucel, Yeni H" uniqKey="Yucel Y" first="Yeni H." last="Yücel">Yeni H. Yücel</name>
<name sortKey="Zhang, Zhexue" sort="Zhang, Zhexue" uniqKey="Zhang Z" first="Zhexue" last="Zhang">Zhexue Zhang</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003513 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003513 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3763898
   |texte=   Latanoprost Stimulates Ocular Lymphatic Drainage: An In Vivo Nanotracer Study
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24049723" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024